BAC vs DTIL Stock Comparison
DTIL currently leads BAC in this stock comparison, with AIQ scores of 59 vs 47. The clearest difference is momentum, while BAC has the stronger risk resilience profile.
What is the main difference between BAC and DTIL?
DTIL leads the current stock comparison as Precision BioSciences, Inc., with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Bank of America Corporation vs Precision BioSciences, Inc.
DTIL leads
DTIL leads by 12 AIQ points, primarily on Momentum.
Fragile: 3 of 6 evidence groups support DTIL, and its current signal state is conflicted.
Bank of America Corporation
Precision BioSciences, Inc.
The Algovestiq AIQ Score currently favors DTIL over BAC, 59 versus 47 as of Oct 31, 2026. DTIL's advantage is driven primarily by stronger momentum, while BAC holds the stronger risk resilience profile. DTIL also shows the stronger technical structure relative to its 50-day moving average. 3 of 6 covered evidence groups favor DTIL today, and the comparison is rated Fragile on stability: only 3 of 6 covered evidence groups agree. DTIL lead: Stable — the AIQ differential has held near 12 points over 30 sessions.
Compare Bank of America Corporation and Precision BioSciences, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare BAC and DTIL against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum26 vs 73DTIL +47
- Risk Resilience60 vs 51BAC +9
- Value57 vs 60Even
- Quality49 vs 51Even
3 of 6 evidence groups favor DTIL. DTIL’s edge is concentrated in momentum; BAC keeps a meaningful risk resilience edge.
What changed since the last close
Latest scored session 2026-10-30, compared against the prior scored session 2026-10-29.
No factor moved materially.
No signal started or stopped since the prior session; its 3 active signals are unchanged.
No factor moved materially.
No signal started or stopped since the prior session; its 8 active signals are unchanged.
DTIL's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — BAC and DTIL both carry a full feed there.
The central trade-off
DTIL (Precision BioSciences, Inc.): the stronger current systematic profile, led by momentum.
BAC (Bank of America Corporation): the counter-case, on risk resilience, fundamentals.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
DTILDTIL on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
BACBAC on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
DTILDTIL on the Momentum factor, by 47 points.
Lower downside
BACBAC on Risk Resilience, by 9 points.
Analyst upside
DTILDTIL on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | BAC | DTIL | Note |
|---|---|---|---|
| Implied upside to target | +32.5% | +183.3% | DTIL has more room |
| Target dispersion | +22.6% | 0% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 11 | 1 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor DTIL. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | DTIL | 47 vs 59 |
| Fundamentals | BACon balance | revenue growth -3.3% vs -100%; EPS growth -23.8% vs -68%; TTM ROE 10.7% vs -91.6%; gross margin 60.4% vs 100%; operating margin 22.4% vs -80.8% — BAC takes 4 of 5 decided legs, not all of them |
| Valuation | Even | Value 57 vs 60 |
| Technicals | DTIL | Price vs 50-day -12.1% vs 1.5%; vs 200-day -7.5% vs 14.8% |
| Risk Resilience | BAC | Risk Resilience 60 vs 51 |
| Analyst expectations | DTIL | Target upside 32.5% vs 183.3% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BAC and DTIL and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is wide at 12 points. (supports the conclusion holding)
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on DTIL.
How the comparison changed
120 daily snapshots · Jul 1 – Oct 30DTIL lead: Stable — the AIQ differential has held near 12 points over 30 sessions.
- Today
- DTIL +12
- 47 vs 59
- 7 sessions ago
- DTIL +7
- 47 vs 54
- 30 sessions ago
- DTIL +13
- 41 vs 54
- 90 sessions ago
- DTIL +5
- 49 vs 54
The lead changed hands 9 times in this window, most recently on Sep 14 when DTIL moved ahead of BAC.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 0 bearish / 1 neutral
No signal that the other name lacks.
5 bullish / 1 bearish / 2 neutral, conflicted
Only DTIL
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.89%)
- BB Upper Band Breach — bearish, volatility, short horizon
- Keltner Channel Breakout — bullish, volatility, short horizon
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Uptrend Structure Active — bullish, trend, long horizon
Both carry 3 more signals that do not separate them: Bollinger Band Squeeze, Golden Cross Active, MACD Bullish Crossover.
DTIL leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -2.21%, AIQ 0 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -5.11%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1BAC closes the Momentum gap — currently 47 points behind, the largest single contributor to DTIL's edge.
- 2BAC's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend.
- 3DTIL's conflicting signal state resolves bearish — it currently carries 5 bullish and 1 bearish rules at once.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
BAC leads on balance| Metric | BAC | DTIL |
|---|---|---|
| Revenue growth (YoY) | -3.3% | -100% |
| EPS growth (YoY) | -23.8% | -68% |
| Gross margin | 60.4% | 100% |
| Operating margin | 22.4% | -80.8% |
| Return on equity (TTM) | 10.7% | -91.6% |
| Debt to equity | 1.28 | 0.62 |
Performance
DTIL leads 6 of 6 windows| Metric | BAC | DTIL |
|---|---|---|
| 1 week (5 sessions) | 0.1% | 11.3% |
| 1 month (20 sessions) | -6.6% | 19.3% |
| 3 months (63 sessions) | -17.6% | 6.7% |
| 6 months (126 sessions) | -3.8% | 8.3% |
| Year to date | -7.5% | 79.6% |
| 1 year (252 sessions) | -3.3% | 11.2% |
Technicals
DTIL has the stronger structure| Metric | BAC | DTIL |
|---|---|---|
| RSI (14) | 31.2 | 63.1 |
| ADX (14) | 49.4 | 14 |
| Price vs 50-day | -12.1% | 1.5% |
| Price vs 200-day | -7.5% | 14.8% |
| Volatility (1M, annualized) | 20.8% | 69.2% |
Risk
BAC is the more resilient| Metric | BAC | DTIL |
|---|---|---|
| Beta | 0.73 | 1 |
| Sharpe ratio | -0.25 | 0.14 |
| Sortino ratio | -0.32 | 0.21 |
| Max drawdown | -22.3% | -58.5% |
| Current drawdown | -21.5% | -19.5% |
| Annualized volatility | 21.8% | 69.2% |
| Value at risk (95%) | -2.5% | -7.5% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, BAC or DTIL?
On the Algovestiq AIQ Score, DTIL is the stronger of the two as of Oct 31, 2026, scoring 59 against BAC's 47. The edge comes from momentum. BAC is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is BAC or DTIL the better buy right now?
DTIL carries the stronger systematic profile as of Oct 31, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 3 of 6 covered evidence groups agree. Treat the lead as provisional.
Why does the AIQ Score favor DTIL over BAC?
The composite weights Quality, Value, Momentum and Risk Resilience. DTIL leads Momentum by 47 points; BAC leads Risk Resilience by 9 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, BAC or DTIL?
Analyst price targets imply +32.5% upside for BAC and +183.3% for DTIL, so the Street currently favors DTIL. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, BAC or DTIL?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, BAC or DTIL?
BAC on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, BAC or DTIL?
DTIL on the Momentum factor, by 47 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, BAC or DTIL?
BAC is the more resilient of the two, so the other name carries the higher downside risk. BAC on Risk Resilience, by 9 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is BAC more profitable than DTIL?
The profitability evidence is mixed: gross margin 60.4% vs 100%; operating margin 22.4% vs -80.8%; ttm roe 10.7% vs -91.6%. BAC leads on two measures and DTIL on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is DTIL's lead over BAC getting stronger or weaker?
DTIL lead: Stable — the AIQ differential has held near 12 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-07-01 and 2026-10-30. The lead has changed hands 9 times in that window, most recently on 2026-09-14, when DTIL moved ahead of BAC.
What would change the BAC vs DTIL verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BAC closes the Momentum gap — currently 47 points behind, the largest single contributor to DTIL's edge; BAC's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend; DTIL's conflicting signal state resolves bearish — it currently carries 5 bullish and 1 bearish rules at once; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about BAC and DTIL?
BAC: 2 bullish / 0 bearish / 1 neutral. DTIL: 5 bullish / 1 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BAC is Golden Cross Active (bullish, long horizon). On DTIL it is Golden Cross Active (bullish, long horizon).
Compare BAC and DTIL with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.